-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Overall accuracy of cancer signal of origin: 83%; By cancer: liver (90%); lung (64%); pancreas (not applicable … Nanomaterial-Assisted LDI for Cancer Identification
N number
NGS next generation sequencing
NA not applicable
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - inhibitors and ARBs have similar rates of treatment adherence
based on pill counts; this result may not be applicable
-
hcup-us.ahrq.gov/db/nation/nass/NASSIntroduction2021.pdf
April 01, 2024 - Introduction To The HCUP Nationwide Ambulatory Surgery Sample
HEALTHCARE COST AND UTILIZATION PROJECT — HCUP
A FEDERAL-STATE-INDUSTRY PARTNERSHIP IN HEALTH DATA
Sponsored by the Agency for Healthcare Research and Quality
INTRODUCTION TO
THE HCUP NATIONWIDE AMBULATORY SURGERY SAMPLE (NASS)
2021
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
February 01, 2012 - Future Research Needs for Diagnosis of Obstructive Sleep Apnea
Future Research Needs Paper
Number 11
Future Research Needs
for Diagnosis of
Obstructive Sleep
Apnea
Future Research Needs Paper
Number 11
Future Research Needs for Diagnosis
of Obstructive Sleep Apnea
Identification of Future Research …
-
hcup-us.ahrq.gov/db/nation/nass/NASSIntroduction2022.pdf
December 01, 2024 - Introduction to the NASS, 2022
HEALTHCARE COST AND UTILIZATION PROJECT — HCUP
A FEDERAL-STATE-INDUSTRY PARTNERSHIP IN HEALTH DATA
Sponsored by the Agency for Healthcare Research and Quality
INTRODUCTION TO
THE HCUP NATIONWIDE AMBULATORY SURGERY SAMPLE (NASS)
2022
These pages pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
January 01, 2020 - We have added further information
regarding why evidence is considered
“insufficient” where applicable … Not
all decision-makers are equally versed in applicable areas of
epidemiology and clinical medicine
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/hospital/2016/2016_hospitalsops_report_pt1.pdf
January 01, 2016 - 140 250 140/250= 56%
Composite Score % Positive = (46% + 52% + 46% + 56%) / 4 = 50%
* NA = Not applicable … NA* 106 240 106/240=44%
* NA = Not applicable.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2021qdr-datasources.pdf
December 31, 2021 - Risk-adjusted rates
for all applicable QIs are provided. … factor of 0.980 to the Outpatient Prospective Payment System (OPPS) payments and
copayments for all applicable
-
hcup-us.ahrq.gov/reports/methods/2005_02.pdf
January 01, 2005 - medical record coders assign the ICD-9-CM diagnosis
codes for ED visits and ICD-9-CM procedure codes if applicable … Beyond this, some specific
challenges to collecting additional data that is applicable to ED settings
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
June 20, 2019 - None Not applicable No controlled studies or observational studies link
screening directly to health … None Not applicable No evidence.
7a 1.
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/mui/mui-screening-toolkit.pdf
April 01, 2025 - EHR to alert providers within a pa-
tient’s medical chart if they screened positively for
UI, and if applicable … your
practice should be mindful of how UI screening aligns
with incentives in your practice and, if applicable
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1368
Published Online: January 2, 2013
Technical Brief Disposition of Comments Report
Resear…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-rapid-research.pdf
April 01, 2024 - Making Healthcare Safer IV Rapid Review: Prevention in Adults of Infection With Transmission of Multidrug-Resistant Organisms
Making Healthcare Safer IV
Prevention in Adults of Transmission of
Infection With Multidrug-Resistant
Organisms
Rapid Review
Structured Abstract
Objectives. This rapid review …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Ks34K-BnsDSBK4MYDATYS
August 09, 2016 - Studies conducted in very high Human Development Index coun-
tries are more likely to be applicable to
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cJSpoZqW2M7czx_-GeTdtE
May 01, 2004 - NA, not applicable.
AHRQ Pub. No. 04-0540-B
May 200429
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
January 01, 2007 - Effectiveness studies that would be most applicable to
the broad population of depressed patients are
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018646-gance-cleveland-final-report-2014.pdf
January 01, 2014 - were rated on a 4-point Likert-type scale from
strongly disagree (1) to strongly agree (4) or not applicable
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
October 01, 2010 - The
following information was obtained from each trial, if
applicable: author identification; year of
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2020_MOSOPS_Part_I-rev0921.pdf
January 01, 2020 - 125 260 125/260= 48%
Composite Measures % Positive Score = (46% + 56% + 48%) / 3 = 50%
*NA = Not applicable
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/failure-to-rescue-1.pdf
March 01, 2020 - This section reviews applicable
studies in more depth, organized by measure type (process and outcome